Li Mingyang, Sun Yuanyuan, Shan Xueting, Tong Yuhong, Fu Yite, Ma Xiang, Sun Zhongxin, Xiang Yun, Zhu Yidan, Wang Tao, Wang Xin, Zhang Jufang, Niu Dong
College of Animal Science and Technology & College of Veterinary Medicine, Zhejiang A&F University, Key Laboratory of Applied Technology on Green-Eco-Healthy Animal Husbandry of Zhejiang Province, Provincial Engineering Research Center for Animal Health Diagnostics & Advanced Technology, Zhejiang International Science and Technology Cooperation Base for Veterinary Medicine and Health Management, China Australia Joint Laboratory for Animal Health Big Data Analytics, 666 Wusu Street, Hangzhou, 311300, Zhejiang, China.
Fourth School of Clinical Medicine, Zhejiang University of Traditional Chinese Medicine, Hangzhou, 310053, China.
Funct Integr Genomics. 2025 Apr 9;25(1):85. doi: 10.1007/s10142-025-01583-4.
Rheumatoid arthritis (RA) is a chronic, inflammatory, autoimmune disease that primarily affects the joints. RA usually results in synovial hyperplasia, expansion of "pannus" and destruction of cartilage. The etiology and pathogenesis of RA are not fully understood, but immunity has been shown to play an important role in the development of autoimmune diseases such as RA. In addition, endogenous retroelements, the remnants of ancient retroviruses in the human genome, are involved in cancer and/or immune disorders. As evidenced by increasing evidences that the aberrant expression of retroelements induces innate immunity, despite the fact that the expression of most retroelements has been epigenetically suppressed over a long period of evolution. With the continuous development of disease-modifying anti-rheumatic drugs (DMARDs), RA disease activity has been alleviated and improved. Unfortunately, some patients have a limited response to DMARDs, and the drugs also have the disadvantages of some side effects and high economic costs. This review summarizes the pathogenic mechanisms of RA and endogenous retroelements in autoimmunity, and concludes with a summary of treatments for RA, along with new therapeutic recommendations.
类风湿关节炎(RA)是一种主要影响关节的慢性、炎症性自身免疫性疾病。RA通常会导致滑膜增生、“血管翳”扩展以及软骨破坏。RA的病因和发病机制尚未完全明确,但免疫已被证明在诸如RA等自身免疫性疾病的发展中起重要作用。此外,内源性逆转录元件,即人类基因组中古代逆转录病毒的残余物,与癌症和/或免疫紊乱有关。越来越多的证据表明,尽管大多数逆转录元件的表达在长期进化过程中已被表观遗传抑制,但逆转录元件的异常表达会诱导先天免疫。随着改善病情抗风湿药(DMARDs)的不断发展,RA的疾病活动得到了缓解和改善。不幸的是,一些患者对DMARDs反应有限,而且这些药物还存在一些副作用和经济成本高的缺点。本综述总结了RA的发病机制以及内源性逆转录元件在自身免疫中的作用,并以RA的治疗总结以及新的治疗建议作为结尾。